Other

Valeant to buy Bausch + Lomb for $8.7B (Update)

Canadian drugmaker Valeant Pharmaceuticals said Monday that it will pay $8.7 billion to buy Bausch + Lomb, one of the world's best-known makers of contact lenses, in a massive expansion of Valeant's smaller ophthalmology ...

Diabetes

Managing diabetes with data and ingenuity

An EU-funded project has developed a device which can predict sugar highs and lows for people with diabetes and provide them with advice on how to manage their glucose levels.

Health

Australia slams 'sick joke' cigarette packs

Australia slammed as a "sick joke" Wednesday new cigarette packs on sale as part of the national phase-in to plain packaging which play on drab branding and claim it's "what's on the inside that counts."

Health

Philip Morris challenges plain packs in Australia

Global tobacco giant Philip Morris Tuesday stepped up its legal campaign against an Australian law banning logos and branding from cigarette packs, saying it had taken its case to the High Court.

Health

BAT challenges Australia cigarette packaging law

British American Tobacco on Thursday launched a High Court challenge against a law that will require plain packaging on cigarettes in Australia, claiming it infringes intellectual property rights.

page 11 from 12